 | Up a level |
Brouwer, N P M; Khan, A; Bokhorst, J M; Ayatollahi, F; Hay, J; Ciompi, F; Simmer, F; Hugen, N; de Wilt, J H W; Berger, M D; Lugli, A; Zlobec, I; Edwards, J; Nagtegaal, I D (2024). The complexity of shapes; how the circularity of tumor nodules impacts prognosis in colorectal cancer. Modern pathology, 37(1), p. 100376. Elsevier 10.1016/j.modpat.2023.100376
Karamitopoulou, Evanthia; Zlobec, I; Born, D; Kondi-Pafiti, A; Lykoudis, P; Mellou, A; Gennatas, K; Gloor, B; Lugli, A (2013). Tumour budding is a strong and independent prognostic factor in pancreatic cancer. European journal of cancer, 49(5), pp. 1032-9. Amsterdam: Elsevier 10.1016/j.ejca.2012.10.022
Lugli, A; Karamitopoulou, Eva; Zlobec, I (2012). Tumour budding: a promising parameter in colorectal cancer. British journal of cancer, 106(11), pp. 1713-7. Basingstoke: Nature Publishing Group 10.1038/bjc.2012.127
Lugli, A; Zlobec, I (2011). Gene signatures in colorectal cancer. In: Russo A, Iacobelli S (ed.) Diagnostic, prognostic and therapeutic value of gene signatures (pp. 115-136). Berlin-Heidelberg: Springer
Dawson, H; Koelzer, V; Inderbitzin, D; Lugli, A; Zlobec, I (2012). Cdx2 loss is a frequent indicator of high-level microsatellite instability (MSI-H) status in colorectal cancer. In: Tag der Klinischen Forschung 2012. Tag der Klinischen Forschung 2012
